Literature DB >> 32500550

The Tumor Microenvironment in Cholangiocarcinoma Progression.

Luca Fabris1,2, Keisaku Sato3, Gianfranco Alpini3,4, Mario Strazzabosco2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32500550      PMCID： PMC7714713          DOI： 10.1002/hep.31410

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.298


× No keyword cloud information.
  88 in total

1.  Genomic spectra of biliary tract cancer.

Authors:  Hiromi Nakamura; Yasuhito Arai; Yasushi Totoki; Tomoki Shirota; Asmaa Elzawahry; Mamoru Kato; Natsuko Hama; Fumie Hosoda; Tomoko Urushidate; Shoko Ohashi; Nobuyoshi Hiraoka; Hidenori Ojima; Kazuaki Shimada; Takuji Okusaka; Tomoo Kosuge; Shinichi Miyagawa; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2015-08-10       Impact factor: 38.330

2.  Prognostic value of neutrophil distribution in cholangiocarcinoma.

Authors:  Zhi-Yuan Mao; Guang-Qing Zhu; Mei Xiong; Li Ren; Li Bai
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

3.  Lymphoepithelioma-like cholangiocarcinoma: an Epstein-Barr virus-associated tumor.

Authors:  Y M Jeng; C L Chen; H C Hsu
Journal:  Am J Surg Pathol       Date:  2001-04       Impact factor: 6.394

Review 4.  Tumour-associated neutrophils in patients with cancer.

Authors:  Merav E Shaul; Zvi G Fridlender
Journal:  Nat Rev Clin Oncol       Date:  2019-10       Impact factor: 66.675

5.  Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.

Authors:  Shin-Ichi Aishima; Ken-Ichi Taguchi; Takahiro Terashi; Shuji Matsuura; Mitsuo Shimada; Masazumi Tsuneyoshi
Journal:  Mod Pathol       Date:  2003-10       Impact factor: 7.842

6.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Authors:  Jesus M Banales; Vincenzo Cardinale; Guido Carpino; Marco Marzioni; Jesper B Andersen; Pietro Invernizzi; Guro E Lind; Trine Folseraas; Stuart J Forbes; Laura Fouassier; Andreas Geier; Diego F Calvisi; Joachim C Mertens; Michael Trauner; Antonio Benedetti; Luca Maroni; Javier Vaquero; Rocio I R Macias; Chiara Raggi; Maria J Perugorria; Eugenio Gaudio; Kirsten M Boberg; Jose J G Marin; Domenico Alvaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-20       Impact factor: 46.802

7.  CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.

Authors:  Yunosuke Nishihara; Shinichi Aishima; Akifumi Hayashi; Tomohiro Iguchi; Nobuhiro Fujita; Akinobu Taketomi; Hiroshi Honda; Masazumi Tsuneyoshi
Journal:  Histopathology       Date:  2009-10       Impact factor: 5.087

Review 8.  Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.

Authors:  Javier Vaquero; Nathalie Guedj; Audrey Clapéron; Thanh Huong Nguyen Ho-Bouldoires; Valérie Paradis; Laura Fouassier
Journal:  J Hepatol       Date:  2016-09-26       Impact factor: 25.083

9.  Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growth.

Authors:  Hiroaki Haga; Irene K Yan; Kenji Takahashi; Joseph Wood; Abba Zubair; Tushar Patel
Journal:  J Extracell Vesicles       Date:  2015-01-02

10.  Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma.

Authors:  Yuki Kitano; Hirohisa Okabe; Yo-Ichi Yamashita; Shigeki Nakagawa; Yoichi Saito; Naoki Umezaki; Masayo Tsukamoto; Takanobu Yamao; Kensuke Yamamura; Kota Arima; Takayoshi Kaida; Tatsunori Miyata; Kosuke Mima; Katsunori Imai; Daisuke Hashimoto; Yoshihiro Komohara; Akira Chikamoto; Takatoshi Ishiko; Hideo Baba
Journal:  Br J Cancer       Date:  2017-11-09       Impact factor: 7.640
View more
  33 in total

Review 1.  Friend and foe: the regulation network of ascites components in ovarian cancer progression.

Authors:  Zhe Geng; Xinxing Pan; Juan Xu; Xuemei Jia
Journal:  J Cell Commun Signal       Date:  2022-10-13       Impact factor: 5.908

Review 2.  Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines.

Authors:  Abdulkadir Isidan; Ali Yenigun; Daiki Soma; Eric Aksu; Kevin Lopez; Yujin Park; Arthur Cross-Najafi; Ping Li; Debjyoti Kundu; Michael G House; Sanjukta Chakraborty; Shannon Glaser; Lindsey Kennedy; Heather Francis; Wenjun Zhang; Gianfranco Alpini; Burcin Ekser
Journal:  Am J Pathol       Date:  2022-05-28       Impact factor: 5.770

3.  Potential of extracellular vesicles and exosomes as diagnostic markers for cholangiocarcinoma.

Authors:  Linping Cao; Jiawei Hong; Jian Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

4.  New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.

Authors:  Leticia Colyn; Gloria Alvarez-Sola; M Ujue Latasa; Carmen Berasain; Maite G Fernandez-Barrena; Matias A Avila; Iker Uriarte; Jose M Herranz; Maria Arechederra; George Vlachogiannis; Colin Rae; Antonio Pineda-Lucena; Andrea Casadei-Gardini; Federica Pedica; Luca Aldrighetti; Angeles López-López; Angeles López-Gonzálvez; Coral Barbas; Sergio Ciordia; Sebastiaan M Van Liempd; Juan M Falcón-Pérez; Jesus Urman; Bruno Sangro; Silve Vicent; Maria J Iraburu; Felipe Prosper; Leonard J Nelson; Jesus M Banales; Maria Luz Martinez-Chantar; Jose J G Marin; Chiara Braconi; Christian Trautwein; Fernando J Corrales; F Javier Cubero
Journal:  J Exp Clin Cancer Res       Date:  2022-05-26

5.  PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for patients with intrahepatic cholangiocarcinoma.

Authors:  Lavinia Patricia Mocan; Rares Craciun; Cristiana Grapa; Carmen Stanca Melincovici; Ioana Rusu; Nadim Al Hajjar; Zeno Sparchez; Daniel Leucuta; Maria Ilies; Mihaela Sparchez; Tudor Mocan; Carmen Mihaela Mihu
Journal:  Cancer Immunol Immunother       Date:  2022-10-17       Impact factor: 6.630

6.  Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer.

Authors:  Dandan Yan; Xianli Ju; Bin Luo; Feng Guan; Huihua He; Honglin Yan; Jingping Yuan
Journal:  BMC Cancer       Date:  2022-10-21       Impact factor: 4.638

Review 7.  Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma.

Authors:  Taek Chung; Young Nyun Park
Journal:  Front Med (Lausanne)       Date:  2022-03-31

Review 8.  The Functional Roles of Immune Cells in Primary Liver Cancer.

Authors:  Linh Pham; Konstantina Kyritsi; Tianhao Zhou; Ludovica Ceci; Leonardo Baiocchi; Lindsey Kennedy; Sanjukta Chakraborty; Shannon Glaser; Heather Francis; Gianfranco Alpini; Keisaku Sato
Journal:  Am J Pathol       Date:  2022-03-23       Impact factor: 5.770

9.  Impact of surgical margin width on long-term outcomes for intrahepatic cholangiocarcinoma: a multicenter study.

Authors:  Hongzhi Liu; Lianku Lin; Ziguo Lin; Yifan Chen; Qizhen Huang; Lei Ding; Jianying Lou; Shuguo Zheng; Xinyu Bi; Jianming Wang; Wei Guo; Fuyu Li; Jian Wang; Yamin Zheng; Jingdong Li; Shi Cheng; Weiping Zhou; Zhangjun Cheng; Yongyi Zeng
Journal:  BMC Cancer       Date:  2021-07-20       Impact factor: 4.430

Review 10.  Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma.

Authors:  Burcin Ekser; Gianfranco Alpini; Keisaku Sato; Wenjun Zhang; Samira Safarikia; Abdulkadir Isidan; Angela M Chen; Ping Li; Heather Francis; Lindsey Kennedy; Leonardo Baiocchi; Domenico Alvaro; Shannon Glaser
Journal:  Hepatology       Date:  2021-06-04       Impact factor: 17.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.